Search research articles
Contact Us
Filters
Showing results (11-20 of 514) with videos related to
Page
of 52
Sort By:
Frontiers in Psychiatry
|
December 11, 2013
Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
Kate Merritt, Philip McGuire, Alice Egerton
Nature Reviews. Neurology
|
March 6, 2023
Psychotic disorders as a framework for precision psychiatry
Fiona Coutts, Nikolaos Koutsouleris, Philip McGuire
Psychopharmacology
|
July 13, 2021
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Edward Chesney, Dominic Oliver, Philip McGuire
Psychological Medicine
|
December 21, 2006
Slow habituation of arousal associated with psychosis proneness
Paul Allen, Daniel Freeman, Philip McGuire
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
January 31, 2012
Is clinical intervention in the ultra high risk phase effective?
Philip McGuire, Sudhakar Selvaraj, Oliver Howes
Cannabis and Cannabinoid Research
|
November 16, 2023
Assessing Cannabis Use in People with Psychosis
Edward Chesney, Will Lawn, Philip McGuire
JAMA Psychiatry
|
November 15, 2023
Concerns Regarding Strength of Conclusions in Systematic Review and Meta-Analysis of Neuroradiological Abnormalities in First-Episode Psychosis-Reply
Graham Blackman, Matthew J Kempton, Philip McGuire
The British Journal of Psychiatry : the Journal of Mental Science
|
May 19, 2026
Academic psychiatry: a key research asset is shrinking
Philip McGuire, Kate Saunders, Belinda R Lennox
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
May 4, 2005
Effect of cannabis use in human brain activity
Rocío Martín-Santos, Zerrin Atakan, Philip McGuire
Lancet (London, England)
|
November 27, 2007
Can antidepressants prevent psychosis?
Paolo Fusar-Poli, Lucia Valmaggia, Philip McGuire
Page
of 52
Search research articles
Search
Showing results (11-20 of 514) with videos related to
Sort By:
Page
of 52
Frontiers in Psychiatry
|
December 11, 2013
Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
Kate Merritt, Philip McGuire, Alice Egerton
Nature Reviews. Neurology
|
March 6, 2023
Psychotic disorders as a framework for precision psychiatry
Fiona Coutts, Nikolaos Koutsouleris, Philip McGuire
Psychopharmacology
|
July 13, 2021
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Edward Chesney, Dominic Oliver, Philip McGuire
Psychological Medicine
|
December 21, 2006
Slow habituation of arousal associated with psychosis proneness
Paul Allen, Daniel Freeman, Philip McGuire
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
January 31, 2012
Is clinical intervention in the ultra high risk phase effective?
Philip McGuire, Sudhakar Selvaraj, Oliver Howes
Cannabis and Cannabinoid Research
|
November 16, 2023
Assessing Cannabis Use in People with Psychosis
Edward Chesney, Will Lawn, Philip McGuire
JAMA Psychiatry
|
November 15, 2023
Concerns Regarding Strength of Conclusions in Systematic Review and Meta-Analysis of Neuroradiological Abnormalities in First-Episode Psychosis-Reply
Graham Blackman, Matthew J Kempton, Philip McGuire
The British Journal of Psychiatry : the Journal of Mental Science
|
May 19, 2026
Academic psychiatry: a key research asset is shrinking
Philip McGuire, Kate Saunders, Belinda R Lennox
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
May 4, 2005
Effect of cannabis use in human brain activity
Rocío Martín-Santos, Zerrin Atakan, Philip McGuire
Lancet (London, England)
|
November 27, 2007
Can antidepressants prevent psychosis?
Paolo Fusar-Poli, Lucia Valmaggia, Philip McGuire
Page
of 52